You are here

patents

Zolgensma patent spat brews between Novartis and Regenxbio as top Novartis gene therapy exec departs

Endpoints

Mon, 09/20/21 - 11:15 am

Medtronic Boasts Recent Victories in Patent War with Axonics

Medical Devices and Diagnostics Industry

Wed, 09/15/21 - 10:44 am

FDA commissioner urges US to crack down on drugmakers' patent abuse

Beckers Hospital Review

Tue, 09/14/21 - 10:36 pm

Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028

Fierce Pharma

Tue, 09/7/21 - 10:43 pm

Bristol Myers Squibb

Gilead wins reversal of $1.2B fine in CAR-T patent fight with Bristol Myers

Fierce Pharma

Thu, 08/26/21 - 08:52 pm

Gilead Sciences

Bristol Myers Squibb

Court upholds AbbVie's patents on blockbuster cancer drug Imbruvica, generics unlikely until 2032

Endpoints

Fri, 08/20/21 - 12:33 pm

Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug

BioSpace

Mon, 08/16/21 - 10:15 pm

Teva Pharmaceutical

Teva’s generic label not skinny enough to protect from $234M damages to GSK

MedCity News

Sat, 08/7/21 - 11:57 pm

Teva Pharmaceutical

Drugs facing the most patent expirations this year

Drug Patent Watch

Sun, 08/1/21 - 11:46 pm

Gilead Sciences

Novartis to pay nearly $178M in lawsuit over BRAF drug — and will be on the hook for royalty

Endpoints

Fri, 07/23/21 - 10:57 am

Cost-cutting generics and biosimilars stuck in legal limbo

MedCity News

Thu, 07/22/21 - 10:58 am

Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst

Fierce Pharma

Tue, 07/13/21 - 11:02 am

The top 15 blockbuster patent expirations coming this decade

Fierce Pharma

Mon, 07/12/21 - 11:08 am

Conformis and Stryker Settle Patent Dispute

Medical Devices and Diagnostics Industry

Wed, 07/7/21 - 10:31 pm

Glaxo needs long-acting HIV gamble to pay off

EP Vantage

Thu, 06/24/21 - 10:57 am

Bristol Myers inks another Revlimid patent settlement—this time with Sun Pharma—as copycats near

Fierce Pharma

Tue, 06/22/21 - 10:49 pm

Bristol Myers Squibb

Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron

Fierce Pharma

Tue, 06/22/21 - 11:56 am

PCSK9 inhibitors

U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel drug

Yahoo/Reuters

Mon, 06/21/21 - 10:28 pm

Perrigo Company

Amarin's Vascepa patent defense ends in a loss at the Supreme Court

Fierce Pharma

Mon, 06/21/21 - 10:09 pm

Gender bias toward men in patent awards results in less biomedical innovation for women, study suggests

Stat

Thu, 06/17/21 - 10:50 pm

gender discrimination

Pages